Anti-ANK3/ ANKYRIN-G/ MRT37 monoclonal antibody
Anti-ANK3/ ANKYRIN-G/ MRT37 antibody for FACS & in-vivo assay
Go to ANK3/ANK3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-MP1989-Ab-1/ GM-Tg-hg-MP1989-Ab-2 | Anti-Human ANK3 monoclonal antibody | Human |
GM-Tg-rg-MP1989-Ab-1/ GM-Tg-rg-MP1989-Ab-2 | Anti-Rat ANK3 monoclonal antibody | Rat |
GM-Tg-mg-MP1989-Ab-1/ GM-Tg-mg-MP1989-Ab-2 | Anti-Mouse ANK3 monoclonal antibody | Mouse |
GM-Tg-cynog-MP1989-Ab-1/ GM-Tg-cynog-MP1989-Ab-2 | Anti-Cynomolgus/ Rhesus macaque ANK3 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-MP1989-Ab-1/ GM-Tg-felg-MP1989-Ab-2 | Anti-Feline ANK3 monoclonal antibody | Feline |
GM-Tg-cang-MP1989-Ab-1/ GM-Tg-cang-MP1989-Ab-2 | Anti-Canine ANK3 monoclonal antibody | Canine |
GM-Tg-bovg-MP1989-Ab-1/ GM-Tg-bovg-MP1989-Ab-2 | Anti-Bovine ANK3 monoclonal antibody | Bovine |
GM-Tg-equg-MP1989-Ab-1/ GM-Tg-equg-MP1989-Ab-2 | Anti-Equine ANK3 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-MP1989-Ab-1/ GM-Tg-hg-MP1989-Ab-2; GM-Tg-rg-MP1989-Ab-1/ GM-Tg-rg-MP1989-Ab-2; GM-Tg-mg-MP1989-Ab-1/ GM-Tg-mg-MP1989-Ab-2; GM-Tg-cynog-MP1989-Ab-1/ GM-Tg-cynog-MP1989-Ab-2; GM-Tg-felg-MP1989-Ab-1/ GM-Tg-felg-MP1989-Ab-2; GM-Tg-cang-MP1989-Ab-1/ GM-Tg-cang-MP1989-Ab-2; GM-Tg-bovg-MP1989-Ab-1/ GM-Tg-bovg-MP1989-Ab-2; GM-Tg-equg-MP1989-Ab-1/ GM-Tg-equg-MP1989-Ab-2 |
Products Name | Anti-ANK3 monoclonal antibody |
Format | mab |
Target Name | ANK3 |
Protein Sub-location | Transmembrane Protein |
Category of antibody | FACS/Biofunctional Antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-ANK3 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | Products Developing | Multi-species ANK3/ ANKYRIN-G/ MRT37 VLP (virus-like particle) (Products Developing) |
Target information
Target ID | GM-MP1989 |
Target Name | ANK3 |
Gene ID | 288,11735,361833,699518,479215,101097842,511203,100062775 |
Gene Symbol and Synonyms | 2900054D09Rik,Ank-3,ANK3,AnkG,Ankyrin-3,ANKYRIN-G,MRT37 |
Uniprot Accession | Q12955,O70511 |
Uniprot Entry Name | ANK3_HUMAN,ANK3_RAT |
Protein Sub-location | Transmembrane Protein |
Category | |
Disease | N/A |
Gene Ensembl | ENSG00000151150 |
Target Classification | N/A |
The target: ANK3, gene name: ANK3, also named as ANKYRIN-G, MRT37. Ankyrins are a family of proteins that are believed to link the integral membrane proteins to the underlying spectrin-actin cytoskeleton and play key roles in activities such as cell motility, activation, proliferation, contact, and the maintenance of specialized membrane domains. Multiple isoforms of ankyrin with different affinities for various target proteins are expressed in a tissue-specific, developmentally regulated manner. Most ankyrins are typically composed of three structural domains: an amino-terminal domain containing multiple ankyrin repeats; a central region with a highly conserved spectrin binding domain; and a carboxy-terminal regulatory domain which is the least conserved and subject to variation. Ankyrin 3 is an immunologically distinct gene product from ankyrins 1 and 2, and was originally found at the axonal initial segment and nodes of Ranvier of neurons in the central and peripheral nervous systems. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Feb 2011].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.